Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
RELMADA THERAPEUTICS, INC. (RLMD)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -102.8% | -93.4% | -65.9% | | | | | |
| ROIC (including intangibles) | -114.5% | -75.7% | -58.9% | -18.6% | 1635.5% | 147.2% | -6447.3% | 2622.8% |
| ROE | -110.3% | -60.4% | -57.6% | -13.1% | -167.2% | 125.5% | -494.3% | -230.3% |
| ROA | -101.3% | -56.3% | -51.5% | -12.9% | -124.5% | -226.9% | -254.5% | -158.3% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | 0.0 | | | | | |
| Days payables outstanding | -2.9 | -16.2 | -25.0 | | | | | |
| Days inventory outstanding | | | | | | | | |
| Cash conversion cycle | 2.9 | 16.2 | 25.0 | | | | | |
|